A Single-Group Study to Evaluate the Effects of an Eyelash Serum on Improving Eyelash Growth

This study will evaluate the efficacy of the DIME Beauty Eyelash Boost Serum in improving the growth of the eyelashes and their appearance in terms of length, fullness, and thickness. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use the test product. Participants will be required to undertake questionnaires at Baseline, Day 30, and Day 60, photos will be taken at Baseline, Day 30, and Day 60, and expert eyelash grading will take place at Baseline and Day 60.

Study Overview

• Status: Completed
• Conditions: Eyelash Growth
• Intervention / Treatment: Other: DIME Beauty Eyelash Boost Serum

• Study Type: Interventional
• Enrollment (Actual): 35
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Santa Monica, California, United States, 90404
      • Citruslabs

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

Females aged 18-65. Wish to improve their eyelash growth. Wish to improve their eyelash length, thickness, and fullness. Have a smartphone or camera to take before-and-after selfies.

Exclusion Criteria:

Anyone not in good health. Anyone who has any chronic health conditions such as oncological or psychiatric disorders.

Anyone who has undergone any procedures that target the eyelashes in the past 3 months, or is planning to in the next 60 days. This includes eyelash lifts, tints, and extensions.

Anyone who has recently started using any product or taking any supplements that target eyelash growth, or who is planning to in the next 60 days.

Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.

Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months.

Anyone who cannot/will not commit to the study protocol. Anyone with a history of substance abuse.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: DIME Beauty Eyelash Boost Serum; Participants will use the eyelash serum twice daily in the morning and evening. The serum will be applied to the base of the top and bottom lashes.

Other: DIME Beauty Eyelash Boost Serum; The test product contains Water, Glycerin, Amino Acids (Sodium PCA, Sodium Lactate, Arginine, Aspartic Acid, PCA, Glycine, Alanine, Serine, Valine, Proline, Threonine, Isoleucine, Histidine, Phenylalanine), Hyaluronic Acid, Panthenol, Aloe Leaf Extract, Niacinamide, Purslane, Chebulic Fruit Extract, Apple Fruit Extract, Tocopherol, Phenoxyethanol, Hexanediol, Ethylhexylglycerin, Biotinoyl Tripeptide-1, Myristoyl Pentapeptide-4.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in eyelash growth as per expert grading. [Timeframe: Baseline to Day 60]	Before & after photos of the eyelashes will undergo grading by an eyelash expert.	60 days
Changes in participant-perceived eyelash growth. [Timeframe: Baseline to Day 60]	Measured via study-specific surveys. Surveys will be adapted from the validated Eyelash Satisfaction Questionnaire and designed on a 5-point Likert scale, with 5 representing the most favorable/best outcome (e.g., "Excellent") and 1 representing the least favorable/worst outcome (e.g., "Very poor").	60 days

Collaborators and Investigators

• Sponsor: Dime Beauty Co.
• Collaborators: Citruslabs

Study record dates

Study Major Dates

• Study Start (Actual): August 23, 2023
• Primary Completion (Actual): February 10, 2024
• Study Completion (Actual): February 10, 2024

Study Registration Dates

• First Submitted: November 4, 2023
• First Submitted That Met QC Criteria: November 4, 2023
• First Posted (Actual): November 9, 2023

Study Record Updates

• Last Update Posted (Estimated): February 22, 2024
• Last Update Submitted That Met QC Criteria: February 20, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 20362

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No